Point Of Care Infectious Disease Testing Market To Reach $15.76 Billion By 2030

August 2024 | Report Format: Electronic (PDF)

Point Of Care Infectious Disease Testing Market Growth & Trends

The global point of care infectious disease testing market size is expected to reach USD 15.76 billion by 2030, registering a CAGR of 4.3%, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices, thus resulting in market growth. The potential in these devices to enable rapid detection of infectious diseases is attributive for the estimated market.

Moreover, revolutionizing patient care brought about by these devices is responsible for the rising demand for decentralized testing settings. Rise in the investments for R&D and development of new products is expected to spur progress in point-of-care infectious disease diagnostics market through to 2025.

For instance, development of a new ‘lab-on-a-disc’ technology developed by an EU project research team aids in the diagnosis of different infectious diseases including malaria. It enables faster diagnosis as a consequence of implementation of point-of-care treatment. This allows precise drugs administration thus influencing adoption rate.


key Request a free sample copy or view report summary: Point Of Care Infectious Disease Testing Market Report


Point Of Care Infectious Disease Testing Market Report Highlights

  • COVID-19 segment dominated the market and accounted for a share of 67% in 2023. This high percentage can be attributed to the rising number of infectious cases and need for fast and accessible diagnostics testing solutions.

  • Lateral flow immunoassay is expected to register the fastest CAGR of 5.7% during the forecast period. The growth can be attributed to increasing prevalence of infectious diseases such as respiratory disease and technological advancements in point of care diagnostics device.

  • The home segment is projected to grow at the fastest CAGR of 5.5% over the forecast period, owing to increasing adoption of point of care testing among geriatric population and increasing emphasis on personalized and preventive home care facilities. 

  • Asia Pacific region is expected to showcase the fastest growth over the forecast period due to rising incidence and prevalence rates of infectious diseases with suitable government support

Point Of Care Infectious Disease Testing Market Segmentation

Grand View Research has segmented the global point of care infectious disease testing market report based on technology, disease, end use, and region:

POC Infectious Disease Testing Technology Outlook (Revenue, USD Billion, 2018 - 2030)

  • Lateral Flow Immunoassay

  • Agglutination Test

  • Flow-through test/Immunoconcentration Assay

  • Molecular Diagnostics

  • Others

POC Infectious Disease Testing Disease Outlook (Revenue, USD Billion, 2018 - 2030)

  • HIV POC

  • Clostridium Difficile POC

  • HBV POC

  • Pneumonia Or Streptococcus Associated Infections

  • Respiratory Syncytial Virus (RSV) POC

  • HPV POC

  • Influenza/Flu POC

  • HCV POC

  • MRSA POC

  • TB & Drug-resistant TB POC

  • HSV POC

  • COVID-19

  • Other Infectious Diseases

POC Infectious Disease Testing End Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Clinics

  • Hospitals

  • Home

  • Assisted Living Healthcare Facilities

  • Laboratory

POC Infectious Disease Testing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in Point Of Care (POC) Infectious Disease Testing Market

  • Abbott

  • Thermo Fisher Scientific Inc

  • F. Hoffmann-La Roche Ltd

  • Siemens Healthineers

  • Becton, Dickinson & Company

  • Chembio Diagnostics Inc.

  • Trinity Biotech

  • Cardinal Health

  • Quest Diagnostics Incorporated

  • Bio-Rad Laboratories Inc.

  • bioMérieux SA

  • Sight Diagnostics Ltd.

  • Gene POC

  • Trivitron Healthcare

  • OJ-Bio Ltd.

  • Ortho-Clinical Diagnostics.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.